Health Discovery Challenges Intel Patent on Method with Genetic Applications | GenomeWeb

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Health Discovery Corporation today announced it has filed a request for the reexamination of a patent held by Intel with applications for the identification of disease genes.

The request to the US Patent and Trademark Office challenges US Patent No. 7,685,077, which grants Intel the rights to the RFE-SVM method as described in the patent entitled, "Recursive Feature Eliminating Method Based on a Support Vector Machine."

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: a global genetic interaction map for Saccharomyces cerevisiae, and progress made in genomics, precision medicine, and therapeutics.

The price of plane tickets can affect how scientists in different countries choose to collaborate with each other, NPR reports.

The Annals of Improbable Research has awarded the 2016 Ig Nobel Prizes.

Scientific American alleges that the FDA has been "arm-twisting journalists into relinquishing their reportorial independence."